Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
JUVÉDERM VOLUMA XC
- Development stage
- Unknown
- Lead developer
- Allergan Aesthetics
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Subcutaneous, Supraperiosteal
01
Overview
JUVÉDERM VOLUMA XC is a sterile, biodegradable, non-pyrogenic, viscoelastic gel implant composed of crosslinked hyaluronic acid (HA) produced by Streptococcus equi bacteria and formulated at a concentration of 20 mg/mL with 0.3% w/w lidocaine in a physiologic buffer. It is designed for deep (subcutaneous and/or supraperiosteal) injection to temporarily restore volume loss in the cheeks, chin, and temple regions due to aging or other causes. The product augments facial contours by adding volume beneath the skin surface, providing immediate lifting effects and improved facial balance. Its mechanism relies on the biophysical properties of crosslinked HA to attract water molecules and provide structural support within soft tissue. Lidocaine is included for local anesthetic effect during injection[1][6][9]. Developed using proprietary VYCROSS technology for enhanced longevity and smooth consistency[9], results can last up to 13 months with optimal treatment[2][8].
- Brand names
- JUVÉDERM VOLUMA XCJuvederm Voluma XC
- Other names
- Voluma
02
Targets
SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)
Beyond the preview
Go deeper on JUVÉDERM VOLUMA XC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JUVÉDERM VOLUMA XC.